Literature DB >> 9602369

Insight into the origin and clonal history of B-cell tumors as revealed by analysis of immunoglobulin variable region genes.

F Stevenson1, S Sahota, D Zhu, C Ottensmeier, C Chapman, D Oscier, T Hamblin.   

Abstract

Recombination of VH, DH and JH genes is a unique first step in normal B-cell development. Subsequent differentiation to a mature plasma cell is accompanied by further events in the Ig genes, including VL-JL joining, somatic hypermutation and isotype switching. Chromosomal changes leading to B-cell tumors can occur at many points in this sequence, and may be partly a consequence of the genetic mobility and mutability permitted in order to generate a diverse antibody repertoire. V genes of neoplastic B cells may reflect the point of maturation reached by the B cell of origin, prior to transformation. Analysis of tumors therefore provides useful information on V-gene patterns in normal B cells, and may add another dimension to classification of B-cell tumors. Transformation may also preserve cell populations normally destined to die by apoptosis. Tumor cells arrested in the site where somatic hypermutation and isotype switch are occurring can still be subject to these processes, and could be influenced by persisting antigen. However, mutation is silenced at the point of exit to the periphery, leading to fixed mutational patterns in tumors of mature B cells. V-gene analysis provides an invaluable tool for understanding the genesis of neoplastic change. It also has a clear clinical relevance in tracking tumor cells, measuring residual disease, and finally in offering the opportunity of developing vaccines for treatment.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9602369     DOI: 10.1111/j.1600-065x.1998.tb01446.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  28 in total

1.  Transcriptional analysis of the B cell germinal center reaction.

Authors:  Ulf Klein; Yuhai Tu; Gustavo A Stolovitzky; Jeffrey L Keller; Joseph Haddad; Vladan Miljkovic; Giorgio Cattoretti; Andrea Califano; Riccardo Dalla-Favera
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-25       Impact factor: 11.205

2.  Histological and immunoglobulin VH gene analysis of interfollicular small lymphocytic lymphoma provides evidence for two types.

Authors:  D W Bahler; N S Aguilera; C C Chen; S L Abbondanzo; S H Swerdlow
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

3.  Splenic marginal zone lymphomas appear to originate from different B cell types.

Authors:  David W Bahler; J Ander Pindzola; Steven H Swerdlow
Journal:  Am J Pathol       Date:  2002-07       Impact factor: 4.307

Review 4.  How do follicular dendritic cells interact intimately with B cells in the germinal centre?

Authors:  Chan-Sik Park; Yong Sung Choi
Journal:  Immunology       Date:  2005-01       Impact factor: 7.397

5.  Improved clonality assessment in germinal centre/post-germinal centre non-Hodgkin's lymphomas with high rates of somatic hypermutation.

Authors:  Mark A Catherwood; David Gonzalez; Caroline Patton; Edwina Dobbin; Lakshmi Venkatraman; H Denis Alexander
Journal:  J Clin Pathol       Date:  2006-06-30       Impact factor: 3.411

Review 6.  Unexpected functions of nuclear factor-κB during germinal center B-cell development: implications for lymphomagenesis.

Authors:  Ulf Klein; Nicole Heise
Journal:  Curr Opin Hematol       Date:  2015-07       Impact factor: 3.284

Review 7.  Somatic hypermutation and B-cell lymphoma.

Authors:  D Dunn-Walters; C Thiede; B Alpen; J Spencer
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-01-29       Impact factor: 6.237

Review 8.  The ezrin-radixin-moesin family of proteins in the regulation of B-cell immune response.

Authors:  Debasis Pore; Neetu Gupta
Journal:  Crit Rev Immunol       Date:  2015       Impact factor: 2.214

9.  YY1 Regulates the Germinal Center Reaction by Inhibiting Apoptosis.

Authors:  Sally E Trabucco; Rachel M Gerstein; Hong Zhang
Journal:  J Immunol       Date:  2016-07-22       Impact factor: 5.422

10.  Autologous lymphoma vaccines induce human T cell responses against multiple, unique epitopes.

Authors:  Sivasubramanian Baskar; Carol B Kobrin; Larry W Kwak
Journal:  J Clin Invest       Date:  2004-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.